Search Result "anti PDL1"
New Treatments for Cutaneous Metastatic Melanoma: MAPK Pathway-Targeted and Immune Based Therapies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 4 Year: 2015 Page: 461-467
Author(s): F. Ranchon,A. Boespflug,C. Rioufol,V. Schwiertz,L. Thomas,S. Dalle
Cancer Stem Cells and Anti-tumor Immunity
Journal: Current Stem Cell Research & Therapy
Volume: 18 Issue: 4 Year: 2023 Page: 445-459
Author(s): Sergei M. Gryaznov,Z. Gunnur Dikmen
Glucocorticoid-induced Tumor Necrosis Factor Receptor Ligand Aggravates Lipopolysaccharide-induced Inflammation by Down-regulating the Programmed Death Ligand in Kupffer Cells
Journal: Current Signal Transduction Therapy
Volume: 10 Issue: 1 Year: 2015 Page: 63-72
Author(s): Kun Xu,Yan Zhang,Si-dong Wei,Pei-zhi Li,Kun He,Jian-ping Gong,Chun Huang
Mechanisms of Anti-PD Therapy Resistance in Digestive System Neoplasms
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 19 Issue: 0 Year: 2024 Page: 1-24
Author(s):
Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11 Issue: 2 Year: 2016 Page: 141-151
Author(s): Xiao-Na Fang,Li-Wu Fu
Anti-angiogenic Drug Resistance: Roles and Targeting of Non-codingRNAs (microRNAs and long non-coding RNAs)
Journal: Current Molecular Pharmacology
Volume: 16 Issue: 8 Year: 2023 Page: 855-869
Author(s): Masoumeh Eliyasi Dashtaki
Research Progress in Small Molecules as Anti-vitiligo Agents
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 8 Year: 2024 Page: 995-1035
Author(s):
Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
Journal: Current Drug Safety
Volume: 11 Issue: 1 Year: 2016 Page: 62-68
Author(s): Assunta Sgambato, Francesca Casaluce, Paola C. Sacco, Giovanni Palazzolo, Paolo Maione, Antonio Rossi, Fortunato Ciardiello, Cesare Gridelli
PD-L1 Signal Transduction Mechanisms in Cancer Cells
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 17 Issue: 2 Year: 2017 Page: 72-86
Author(s): Miren Zuazo-Ibarra,Maria Gato-Canas,Hugo Arasanz-Esteban,Gonzalo Fernandez-Hinojal,Maria Ibanez-Vea,Luisa Chocarro,Ruth Vera-Garcia,David Escors,Grazyna Kochan
Status of Programmed Death Ligand 1 (PD-L1) by Immunohistochemistry and Scoring Algorithms
Journal: Current Drug Targets
Volume: 21 Issue: 13 Year: 2020 Page: 1286-1292
Author(s): Francesca Giunchi,Thomas Gevaert,Marina Scarpelli,Michelangelo Fiorentino